MUCORMYCOSIS
Clinical trials for MUCORMYCOSIS explained in plain language.
Never miss a new study
Get alerted when new MUCORMYCOSIS trials appear
Sign up with your email to follow new studies for MUCORMYCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Korean study confirms Cresemba's safety for deadly fungal infections
Disease control CompletedThis study looked at how safe and effective the drug Cresemba is for adults in Korea with serious fungal infections like invasive aspergillosis or mucormycosis. Researchers tracked side effects and how well patients responded to treatment. The goal was to gather real-world safety…
Matched conditions: MUCORMYCOSIS
Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 07:40 UTC
-
Real-World data reveals Isavuconazole's effectiveness against deadly fungal infections
Knowledge-focused CompletedThis study reviewed medical charts of 307 adults in five European countries who were treated with isavuconazole for invasive aspergillosis or mucormycosis. Researchers tracked how patients responded to treatment at 6, 12, and 24 weeks, including symptom improvement, imaging resul…
Matched conditions: MUCORMYCOSIS
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 26, 2026 07:46 UTC
-
COVID-19's hidden toll: fungal infections in transplant patients under the microscope
Knowledge-focused CompletedThis study looked at 60 blood cancer patients who had a stem cell transplant and later developed a serious fungal infection called mucormycosis. Researchers compared cases before COVID-19 (2015-2020) and during the pandemic (2020-2024) to see how the virus, new tests, and treatme…
Matched conditions: MUCORMYCOSIS
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 26, 2026 07:43 UTC